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31 Abstract
32 Human Prader-Willi syndrome (PWS) is characterised by impairments of multiple 
33 systems including the growth hormone (GH) axis and skeletal growth.  To address our 
34 lack of knowledge of the influence of PWS on skeletal integrity in mice, we have 
35 characterised the endocrine and skeletal phenotype of the PWS-ICdel mouse model for 
36 “full” PWS and determined the impact of thermoneutrality.
37 Tibial length, epiphyseal plate width and marrow adiposity were reduced by 6%, 18% 
38 and 79% in male PWS-ICdel mice, with osteoclast density being unaffected.  Similar 
39 reductions in femoral length accompanied a 32% reduction in mid-diaphyseal cortical 
40 diameter.  Distal femoral Tb.N was reduced by 62%, with individual trabeculae being 
41 less plate-like and the lattice being more fragmented (Tb.Pf increased by 63%).  Cortical 
42 strength (Ultimate moment) was reduced by 26% as a result of reductions in calcified 
43 tissue strength and the geometric contribution.  GH and prolactin contents in PWS-ICdel 
44 pituitaries were reduced in proportion to their smaller pituitary size, with circulating IGF-1 
45 concentration reduced by 37-47%.  Conversely, while pituitary LH content was halved, 
46 circulating gonadotropin concentrations were unaffected.  Although longitudinal growth, 
47 marrow adiposity and femoral geometry were unaffected by thermoneutrality, 
48 strengthened calcified tissue reversed weakened cortex of PWS-ICdel femora.
49 While underactivity of the GH-axis may be due to loss of Snord116 expression and 
50 impaired limb bone geometry and strength due to loss of Magel2 expression, 
51 comprehensive analysis of skeletal integrity in the single gene deletion models is 
52 required.   Our data imply that thermoneutrality may ameliorate the elevated fracture risk 
53 associated with PWS.
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54 Introduction
55 Prader-Willi syndrome (PWS) is a neurodevelopmental disorder arising from the loss of 
56 expression of one or more genes from the paternal allele of the PWS locus (Butler et al, 
57 2016).  The PWS phenotype is complex, characterised by neonatal hypotonia and an 
58 initial failure to thrive (Miller et al, 2011), the subsequent development of hyperphagia 
59 (Miller et al, 2011), hyperghrelinaemia (Cummings et al, 2002), and growth hormone 
60 (GH) deficiency (Grosso et al, 1998), resulting in severe truncal obesity and growth 
61 retardation (Kahn et al, 2018).
62
63 By manipulating the murine PWS locus on chromosome 7, several mouse models for 
64 this condition have linked the contribution of individual PWS genes to specific phenotypic 
65 characteristics.  For example, while loss of the MAGE-family gene, Necdin has no effect 
66 on growth or adiposity (Cattanach et al, 1992, Muscatelli et al, 2000) Necdin-null mice 
67 display enhanced differentiation and/or proliferation of astrocytes (Fujimoto et al, 2016), 
68 neocortical neural precursor cells (Minamide et al, 2014), hematopoietic stem cells (Asai 
69 et al, 2012) and pre-adipocytes (Fujiwara et al, 2012).  Similarly, although deletion of 
70 another MAGE-family gene, Magel2, fails to induce hyperphagia with standard diets 
71 (Bischof et al, 2007), Magel2-null mice display impaired GH axis function (Tennese & 
72 Wevrick, 2011) and leptin sensitivity (Pravdivyi et al, 2015), accompanied by a doubling 
73 of fat mass (Bischof et al, 2007).   In contrast, loss of the small nucleolar (sno)RNA, 
74 Snord116, results in mild hyperphagia and impaired meal-termination, but accompanied 
75 by intra-abdominal leanness (Ding et al, 2008).  
76
77 Such studies have revealed features of PWS not commonly reported in humans.  For 
78 example, our study of metabolic homeostasis in the PWS-ICdel mouse, in which paternal 
79 inheritance of an imprinting centre (IC) deletion results in a complete lack of gene 
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80 expression from the entire PWS interval (Chamberlain et al, 2004), revealed overactive 
81 brown fat and excess heat production (Golding et al, 2017).  Unlike humans with PWS 
82 (Kahn et al, 2018), PWS-ICdel mice display profound abdominal leanness, probably 
83 resulting from a compromised capacity of PWS adipocytes to import lipid (Golding et al, 
84 2017), a phenomenon reported in isolated human PWS adipocytes (Cadoudal et al, 
85 2014).  
86
87 Disruption of adipocyte function has extra-metabolic consequences.  For example, there 
88 is a bi-directional relationship between fat and bone (Leiben et al, 2009), with bone 
89 marrow adipocytes and the bone-forming osteoblasts arising from the same 
90 mesenchymal stem cells (MSCs) (Beresford et al, 1992, Di Iorgi et al, 2008) and 
91 osteogenesis being influenced by leptin (Thomas et al, 1999, Hamrick et al, 2005, Evans 
92 et al, 2011).  Although several studies have examined the effects of the loss of specific 
93 PWS interval regions/genes on bone (Khor et al, 2016, Kamaludin et al, 2016, 
94 Baraghithy et al, 2019), a study of the impact of losing all of the genes in the PWS locus 
95 is lacking.  We have therefore conducted a study of the growth, morphology, 
96 microarchitecture and biomechanical properties of the appendicular bones of PWS-ICdel 
97 mice and characterised the underlying endocrine phenotype.  In addition, since we have 
98 recently shown that maintaining PWS-ICdel mice at thermoneutrality may reduce 
99 proportionate hyperphagia (Golding et al, 2017), we quantified the effect of this 
100 manipulation on bone morphology and strength.
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101 Materials and Methods
102
103 Animals
104 The mice used in this study were bred under the authority of the Animals (scientific 
105 procedures) Act 1986 (UK), with subsequent procedures conforming with the ARRIVE 
106 guidelines and specifically approved by the Cardiff University Animal Welfare Ethical 
107 Review Body (AWERB).
108
109 PWS-ICm+/p- (referred to throughout as PWS-ICdel) and wild-type (WT) littermates were 
110 generated by crossing ICdel-positive males with WT females.  Given that PWS-ICdel 
111 animals on a pure C57BL/6J background suffer severe postnatal lethality (Yang et al, 
112 1998), we crossed ICdel positive males with CD1 females and selectively culled WT 
113 littermates (identified on the basis of their increased size 48 hours after birth) leaving 
114 only 1 or 2 WT pups per litter (Chamberlain et al, 2004).  Animals were weaned at 
115 approximately 4 weeks of age and housed in single-sex groups with WT littermates (2-5 
116 animals per cage).
117
118 All animals were maintained on a 12hr light/dark cycle (lights on 07:00h) at 20-22°C 
119 (unless otherwise stated), with ad libitum access to water and standard laboratory chow 
120 (Rat and Mouse No. 3 Breeding Diet, Special Diet Services Ltd., Witham, Essex, UK, 
121 containing 4.2% crude fat; 22.4% crude protein; 4.2% crude fibre; 7.6% crude ash (see 
122 Tilston et al, 2019 for full dietary composition).
123
124 Study 1.  Tibial growth and marrow adiposity in PWS-ICdel mice
125 After an overnight fast (with water available ad libitum), 18-month old male PWS-ICdel 
126 and WT littermates were killed by cervical dislocation.   Left tibiae were excised, the 
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127 length determined with a hand-held micrometer and fixed in buffered formal saline for 
128 48hrs at 4°C before being decalcified in 0.5M EDTA (pH 7.6).  Tibiae were stored in 70% 
129 ethanol at 4°C prior to quantifying epiphyseal plate width (EPW), marrow adiposity and 
130 osteoclast number (see below).  
131
132 Study 2.  Femoral phenotype in PWS-ICdel mice
133 Left femora were excised from the mice in study 1, soft tissue removed and length 
134 measured with a hand-held micrometer.  Femora were wrapped in saline-soaked gauze, 
135 snap frozen and stored at -80°C for subsequent µ-CT and biomechanical analysis (see 
136 below).
137
138 Study 3.  Endocrine status in PWS-ICdel mice
139 Male and female PWS-ICdel and their 6-15-month old WT littermates were anaesthetised 
140 with isoflurane and killed by decapitation.  Pituitaries were dissected, weighed, snap 
141 frozen and stored at -80°C for subsequent quantification of growth hormone (GH), 
142 prolactin (PRL) and luteinising hormone (LH) content (see below).
143
144 Male and female PWS-ICdel and their 5-9-month old WT littermates were anaesthetised 
145 with isoflurane and killed by decapitation.  Pituitaries were dissected and weighed and 
146 trunk blood collected into EDTA-coated tubes, vortexed and centrifuged.  Aliquots of 
147 separated plasma were snap frozen and stored at -80°C for subsequent quantification of 
148 circulating insulin-like growth factor-1 (IGF-1), LH and follicle stimulating hormone (FSH) 
149 (see below).
150
151 Study 4.  The effect of thermoneutrality on skeletal parameters in PWS-ICdel mice
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152 Male and female PWS-ICdel and their 6-15-month old WT littermates were group-housed 
153 in standard mouse cages (2-3 mice /cage) at 20-22°C or at thermoneutrality (30°C) 
154 (Golding et al, 2017).  After 9 weeks, mice were anaesthetised with isoflurane and killed 
155 by decapitation.  Tibiae and femora were excised and processed as above (studies 1 & 
156 2) for subsequent quantification of growth, adiposity, geometry and strength.
157
158 Quantification of tibial epiphyseal plate width and marrow adiposity
159 Tibial EPWs and marrow adiposity were measured as previously described (Gevers et 
160 al, 2002; Thompson et al, 2004, Navein et al, 2016, Hopkins et al, 2017).   In brief, three 
161 7µm anterior-posterior longitudinal tibial sections were stained with Masson’s Trichrome 
162 and visualised under light microscopy.  Total plate width was measured in triplicate on 
163 digitally captured images of each section using the interactive feature tool of Leica QWin 
164 (V3.2).  Marrow adiposity was quantified on digital images of mid-diaphyseal marrow and 
165 photomicrographs analysed with National Institutes of Health (NIH) Image J, to quantify 
166 %-adiposity, and the number and size of marrow adipocytes.
167
168 Quantification of tibial osteoclasts
169 To identify osteoclasts, consecutive paraffin sections were de-parraffinised, stained for 
170 tartrate-resistant acid phosphatase (TRAP; Sigma-Aldrich), and counterstained with 
171 Mayer’s haematoxylin. Histomorphometric analysis was performed on digital 
172 photomicrographs using IMAGE-PRO PLUS V.6 (Media Cybernetics, Silver Spring, MD) 
173 to determine the number of TRAP+ osteoclasts per bone surface (N.Oc/BS). 
174
175 Quantification of femoral trabecular architecture
176 The trabecular microarchitecture of the distal femora was assessed using a high-
177 resolution µ-CT system (Bruker Skyscan 1272, Kontich, Belgium) as previously 
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178 described in rats (Evans et al, 2011) and mice (Navein et al, 2016).  Femora were 
179 thawed, mounted on the sample presentation stage and orientated by taking a series of 
180 single images.   Scanning was conducted at 70kV and 142µA, using a resolution of 
181 9.04µm, 990 millisecond exposures, a rotation step of 0.60° and a 0.5mm aluminium 
182 filter.   Analysis was performed according to the ASBMR guidelines (Bouxsein et al, 
183 2010).  In brief, a 1mm3 ROI of secondary spongiosa 0.5mm above the centre of the 
184 distal epiphyseal plate was analyzed using the CT image analysis software (CT-An; 
185 https://www.bruker.com/products/microtomography/micro-ct-software/3dsuite.html).   
186 Trabecular bone was separated from cortical bone within the area of interest by using 
187 the freehand drawing tool in CT-An.  After scanning, femora were re-wrapped in saline-
188 soaked gauze and re-frozen and for strength testing.   
189
190 Biomechanical testing
191 Mechanical strength of the femoral cortex was quantified by three-point bending as 
192 previously described (Stevenson et al, 2009, Navein et al, 2016), with the lower rollers 
193 set at 6.42 and 4.04 mm apart for WT and PWS-ICdel femora respectively and the central 
194 roller positioned equidistant from the lower rollers over the thinnest part of the mid-
195 diaphyseal region, to give an approximately posterior load direction.  Femora were 
196 loaded at a crosshead speed of 2mm/min until failure, with load and displacement data 
197 recorded by a Zwick Z050 tensile testing machine fitted with a 1kN load cell (Zwick 
198 Testing Machines Ltd., Leominster, United Kingdom).   Ultimate tensile stress was 
199 calculated using failure load, morphometric measurements of cortical wall thicknesses 
200 and diameter (taken from cross-sectional µ-CT images corresponding to the fracture site 
201 as determined by measuring the distance from the end of the femur to the fracture point 
202 using a hand-held micrometer) and simple beam theory.
203
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204 Hormone Quantification
205 Pituitaries were homogenized in 0.5ml lysis buffer (TRIS 0.1M pH 7.4, NaCl 0.15M, 
206 EGTA 1mM, EDTA 1mM, Triton 1%, Protease inhibitor cocktail (Sigma-Aldrich, P8340) 
207 and Phosphatase inhibitor cocktail 3 (Sigma- Aldrich, P0044)), maintained on ice for 30 
208 mins and centrifuged for 10 mins at 13000g.  Protein concentration was measured in a 
209 1:100 dilution of 4µl of the supernatant with the QuantiPro BCA assay kit (Sigma Aldrich, 
210 QPBCA-1KT) using protein standards (Sigma-Aldrich, P0914).  Samples were diluted in 
211 PBS to normalize protein concentration. GH, LH and PRL levels were measured using 
212 sandwich ELISAs (Steyn et al, 2011; Steyn et al, 2013, Guillou et al, 2015).
213
214 Plasma IGF-1 concentrations were determined in duplicate using a rat/mouse total IGF-1 
215 immunoenzymometric assay (OCTEIA® Immunodiagnostic Systems Ltd., #AC-18F1) 
216 according to the manufacturer’s instructions, with samples pre-treated to avoid binding 
217 protein interference.  LH and FSH levels were measured in plasma samples using 
218 radioimmunoassay reagents provided by the National Institutes of Health (Dr. A. F. 
219 Parlow, Torrance, CA, USA).  Rat LH-I-10 and FSH-I-9 were labeled with 125I by the 
220 chloramine-T method, and LH and FSH concentrations expressed using reference 
221 preparations LH-RP-3 and FSH-RP-2 as standards.  Intra- and inter-assay coefficients of 
222 variation were <8% and <10% for LH and <6% and <9% for FSH, respectively.  Assay 
223 sensitivities were 5 pg/tube for LH and 20 pg/tube for FSH.
224
225 Statistical analyses
226 Results are expressed as mean ± SEM, and compared by unpaired Student’s t-test or 1-
227 way ANOVA and Bonferroni’s selected pairs post hoc test (using GraphPad Prism, 
228 GraphPad Software Inc., San Diego. CA., USA), as indicated in the figure legends, with 
229 P < 0.05 considered significantly different.
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232 Study 1.  Tibial growth and marrow adiposity in PWS-ICdel mice
233 Tibial length and EPW were reduced in PWS-ICdel males by 6% (P<0.001; Fig 1A) and 
234 18%  (P<0.01; Fig 1B) respectively.  A profound (79%) reduction in tibial marrow 
235 adiposity (P<0.05; Fig 1C and inset pictures a & b) was due to a combination of a 53% 
236 reduction in marrow adipocyte number (P<0.05; Fig 1D) and a 48% reduction in mean 
237 adipocyte size (P<0.05; Fig 1E).  Adipocyte size profiling (Fig 1F) revealed a loss of 
238 larger adipocytes, especially those >825µm2 (P<0.05).
239
240 Analysis of TRAP+-stained sections revealed a 62% reduction in tibial osteoclast number 
241 (P<0.05; data not shown), but when corrected for the 65% reduction in tibial trabecular 
242 surface (P<0.05; data not shown), the osteoclast density was unaffected (P=0.403; Fig 
243 1G).
244
245 Study 2.  Femoral phenotype in PWS-ICdel mice
246 A 4% reduction in femoral length in PWS-ICdel mice (P<0.05; Fig 2A) was accompanied 
247 by a 32% reduction in cortical (anterior-posterior) diameter (P<0.05; Fig 2B) with mean 
248 cortical wall thickness in PWS-ICdel mice being 73% of that in WT littermates (P=0.055; 
249 Fig 2C).  µCT analysis revealed that trabecular number (Tb.N) in the distal femora of 
250 PWS-ICdel mice was reduced by 62% (P<0.01; Fig 2D).  Although the overall trabecular 
251 thickness (Tb.Th) was unaffected (P=0.110; Fig 2E), the cross-sectional shape became 
252 more cylindrical (less plate-like) in PWS-ICdel mice (structural modal index (SMI) 
253 increased by 25%; P<0.05; Fig 2F).  Trabecular surface was reduced in PWS-ICdel 
254 femora by 72% (P=0.0006; data not shown), but when corrected for the 77% reduction in 
255 trabecular volume (P=0.0009; data not shown), relative trabecular surface (BS/BV) was 
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256 increased by 29% (P<0.01; Fig 2G).  These changes were accompanied by an 18% 
257 increase in trabecular separation (Tb.Sp; P<0.01; Fig 2H) and a marked fragmentation of 
258 the trabecular lattice (63% increase in Pattern factor (Tb.Pf; P<0.05; Fig 2I).  Although 
259 mean degree of anisotropy in PWS-ICdel mice was 125% of that in WT littermates, this 
260 index of trabecular orientation was not significantly different (P=0.098; data not shown).
261  
262 Biomechanical strength of PWS-ICdel femoral cortex was reduced by 26% (ultimate 
263 moment; P<0.05; Fig 3A).   This was due to an 80% decrease in the geometric 
264 contribution to strength (second moment of area; P<0.05; Fig 3C), the strength of the 
265 calcified tissue (ultimate tensile stress; UTS) being increased by 65% (P<0.05; Fig 3B).
266
267 Study 3.  Endocrine status in PWS-ICdel mice
268 To investigate whether skeletal impairment might be due to endocrine dysfunction, we 
269 quantified pituitary and circulating hormone concentrations.  Although not sexually 
270 dimorphic in either WT or PWS-ICdel mice, pituitary weight was reduced in both male and 
271 female PWS-ICdel mice by 35% and 43% respectively (P<0.01 and P<0.001; Fig 4A).  
272 Similarly, pituitary GH content was reduced by 42% and 56% in male and female PWS-
273 ICdel mice (P<0.05; Fig 4B), in proportion to protein content (data not shown).  While 
274 average pituitary PRL content in male PWS-ICdel mice was only 45% of that in WT 
275 males, this was not significantly different (P>0.05).  In contrast, female PWS-ICdel mice 
276 showed a 41% reduction in PRL content (P<0.05; Fig 4C); the marked sexual 
277 dimorphism seen in WT mice (P<0.0001) being retained in PWS-ICdel littermates 
278 (P<0.01; Fig 4C).  This sexual dimorphism (P<0.0001), but not PRL deficiency, was 
279 retained when PRL contents were corrected for protein content (data not shown).  Male 
280 PWS-ICdel mice showed a marked (58%) reduction in pituitary LH content (P<0.0001; Fig 
281 4D), but while mean LH content in female PWS-ICdel mice was only 54% of that in WT 
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282 females, this was not significantly different (P=0.535; Fig 4D).  In addition, the marked 
283 sexual dimorphism in LH content seen in WT mice (P<0.0001) was not replicated in 
284 PWS-ICdel littermates (P=0.412).  These differences in LH content remained after 
285 correction for protein content (P<0.05; data not shown).
286
287 Circulating IGF-1 was reduced in male and female PWS-ICdel mice by 47% and 37% 
288 respectively (P<0.0001 and P<0.001; Fig 5B).  Although mean plasma LH and FSH 
289 concentration in PWS-ICdel males were 163% and 123% of that in male WT littermates, 
290 these were not significantly different (P>0.900; Fig 5C & D).  Plasma LH and FSH 
291 concentrations were comparable in WT and PWS-ICdel females and there was no sexual 
292 dimorphism in circulating gonadotrophin levels in either genotype (Fig 5C & D).
293
294 Study 4.  The effect of thermoneutrality on skeletal parameters in PWS-ICdel mice
295 As in study 1, tibial length in male PWS-ICdel mice at standard ambient temperature were 
296 reduced by 11% (P<0.0001; Fig 6A), with a similar (10%) reduction in females 
297 (P<0.0001; data not shown).  This difference was maintained at thermoneutrality in 
298 males (9% reduction; P<0.001; Fig 6A) and females (8% reduction; P<0.0001), 
299 thermoneutrality having no effect on either tibial length nor EPW in either genotype (Fig 
300 6A & B).
301
302 Mean tibial marrow adiposity and adipocyte number in PWS-ICdel mice at standard 
303 ambient temperature were only 22% and 29% of that in WT males, but given the 
304 variation in the WT data, these were not statistically different (P=0.5668 (adiposity); Fig 
305 6C; P=0.3388 (adipocyte number); Fig 6D).  Thermoneutrality had no statistically 
306 significant effect on tibial marrow adiposity (Fig 6C) or adipocyte size in either WT or 
307 PWS-ICdel males (Fig 6E).  Parallel results were also obtained in females (data not 
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308 shown).  Analysis of the adipocyte size profile revealed that while differences were seen 
309 between PWS-ICdel males and their WT littermates at room temperature (e.g. there were 
310 less adipocytes in the size range 525-572µm2 in PWS-ICdel mice (Fig 6F; P=0.038)), 
311 these differences were abolished in mice maintained at thermoneutrality (Fig 6G).
312
313 As above, femoral length and cortical diameter were reduced by 8% and 25% in male 
314 PWS-ICdel mice at 20-22°C (P<0.0001; Fig 7A & B), with average cortical wall thickness 
315 not being significantly different (Fig 7C).  None of these geometric variables were altered 
316 by increasing the ambient temperature to thermoneutrality (Fig 7A-C).  However, the 
317 48% reduction in the biomechanical strength of the femoral cortex in PWS-ICdel mice at 
318 room temperature (P<0.0001; Fig 7D), was abolished when PWS-ICdel mice were 
319 maintained at thermoneutrality (Fig 7D).  This improvement in biomechanical 
320 performance was entirely due to the significant increase in the strength of the calcified 
321 tissue, UTS in PWS-ICdel mice at 30°C being 91% higher than in WT littermates at 
322 thermoneutrality (P<0.01; Fig 7E).  In the absence of any significant effect of 
323 thermoneutrality on femoral geometry, there was no change in the geometric contribution 
324 to strength, which remained at 32% of that in WT mice (Fig 7F).  Similar results were 
325 obtained in females, the impaired biomechanical strength in PWS-ICdel mice at 20-22°C 
326 (P=0.007), being ameliorated at thermoneutrality (P=0.215), as a consequence of the 
327 contribution of tissue strength, the impaired geometric contribution being exacerbated 
328 (P=0.006) (data not shown).
329
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330 Discussion
331 Loss of gene expression from the paternal allele of chromosome 15q11-q13 results in 
332 the marked disturbances in neural development, hormone secretion and metabolic 
333 homeostasis that characterise PWS.  However, despite impaired GH secretion and GH 
334 replacement long being considered a key feature of this condition and an important 
335 element in therapeutic strategy (Lee et al, 1987; Deal et al, 2013; Carias & Wevrick, 
336 2019), our understanding of the significance of GH-deficiency for skeletal growth and 
337 integrity in the preclinical animal models of PWS is surprisingly superficial.   To address 
338 this gap in our knowledge, we have analysed the phenotype of the weight-bearing long 
339 bones of the PWS-ICdel mouse model for “full” PWS, shedding new light on the 
340 mechanisms of fracture risk in this complex condition.
341
342 Three prominent features of the observed skeletal phenotype deserve comment: 
343 impaired morphometric growth, impaired marrow adiposity and impaired biomechanical 
344 strength.
345
346 Preliminary evidence of growth retardation has been reported in most of the murine 
347 models for PWS, including mice with uniparental disomy (Cattanach et al, 1992) and 
348 deletions of Snrpn-Ube3a (Tsai et al, 1999a), Snurf/Snrpn exon 2 (Tsai et al, 1999b), 
349 Snord116 (Ding et al, 2008) and Magel2 (Bischof et al, 2007; Baraghithy, 2019), with 
350 Necdindel mice showing normal growth (Tsai et al, 1999a).  However, initial attempts to 
351 quantify skeletal growth following IC deletion, in which expression of all the genes in the 
352 PWS locus is lost, have been hampered by high neonatal mortality (Yang et al, 1998).  
353 Having developed a breeding strategy to partially overcome this problem, we now report 
354 that PWS-ICdel mice display consistent shortening of appendicular bones.
355
Page 14 of 37Accepted Manuscript published as JOE-19-0279.R1. Accepted for publication: 19-Aug-2019
Copyright © 2019 Society for Endocrinology Downloaded from Bioscientifica.com at 08/29/2019 12:04:14PM
via Cardiff University
356 This growth impairment is most likely to result from the marked deficiency in the GH-IGF-
357 1 axis (40-50% reductions in both pituitary GH content and circulating IGF-1).  Although 
358 we cannot exclude a potential reduction in GH sensitivity, it is evident from comparison 
359 with other murine models for isolated GH-deficiency (GH-D) or reduced GH signalling 
360 that the degree of growth retardation in mice appears to reflect the severity of axis 
361 inactivation, with complete loss of GH secretion/signalling producing the most severe 
362 phenotype (20-25% reduction in body length; Alba and Salvatori, 2004; Zhou et al, 1997; 
363 Stevenson et al, 2009).
364
365 It is important to note, however, that femoral diameter (reduced by 32% in PWS-ICdel 
366 mice) was more profoundly affected than longitudinal growth.  This occurred without 
367 affecting cortical wall thickness.  Although broadly similar findings in mice with reduced 
368 GH signalling (Stevenson et al, 2009) suggest that loss of GH activity may be an 
369 important determinant, the fact that cortical diameter is only reduced by 17% in the 
370 complete absence of GH-receptors implies that other factors in the PWS endotype may 
371 contribute to this diminution of diameter.
372
373 While GH-deficiency may be the most likely cause, we cannot exclude the potentially 
374 negative influence of gonadotropin deficiency on bone formation (Yarram et al, 2003).  In 
375 contrast, the observed PRL-deficiency is unlikely to represent a significant factor in this 
376 context as PRL has been shown to inhibit osteoblast function (Cross et al, 2000).  
377 However, given the growing evidence for impaired oxytocin signalling in mouse models 
378 for PWS (Schaller et al, 2010), further analysis should investigate the potentially 
379 negative impact of oxytocin loss on the skeletal phenotype (Elabd et al, 2008).
380
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381 A potential physical mechanism relates to the marked reduction in body weight (reduced 
382 by 40%) and adiposity (individual fat pad weights reduced by 67-84%) seen in PWS-ICdel 
383 mice (Golding et al, 2017).  This leanness has a number of consequences.  Firstly, the 
384 loading forces being applied to these weight bearing bones are significantly reduced.  
385 These forces promote the remodelling of the bone to enhance diameter and weight-
386 bearing capacity (David et al, 2007; Luu et al, 2009).  Although muscle mass was not 
387 quantified in the current study, muscle hypoplasia in the Magel2del mouse model for 
388 PWS/Schaaf-Yang syndrome (SYS) (Kamaludin et al, 2016), indicates that this could 
389 represent a possible transduction mechanism.  Secondly, such profound reductions in 
390 abdominal fat mass are likely to cause a dramatic reduction in circulating leptin.  Any 
391 effect of hypoleptinaemia is likely to be enhanced by changes in the marrow milieu 
392 resulting from the equally dramatic reduction in marrow adiposity in this model.
393
394 This marked decline in tibial marrow adiposity is due to reductions in both marrow 
395 adipocyte number and size.  While the latter parallels the changes we previously 
396 reported in intra-abdominal white adipose tissue (Golding et al, 2017), our current data 
397 indicates that in the bone marrow at least, impaired adipogenesis is also a significant 
398 factor.  In the context of the barrage of endocrine signals promoting marrow adiposity, 
399 this is quite remarkable.  For example, dw/dw rats, which show a similar degree of GH-D 
400 accompanied by intra-abdominal leanness, show elevated marrow adiposity (mainly 
401 increased adipogenesis) (Gevers et al, 2002), with GH treatment inhibiting adipogenesis 
402 and triglyceride storage (Gevers et al, 2002).  In addition, since ghrelin is powerfully 
403 adipogenic in bone marrow (Thompson et al, 2004; Davies et al, 2009; Hopkins et al, 
404 2017), the marked hyperghrelinaemia in PWS-ICdel mice (Golding et al, 2017) should 
405 elevate marrow adiposity.  Clearly, the anti-adipogenic signals in PWS-ICdel mice are 
406 more than sufficient to reverse these influences.  The absence of the larger adipocytes in 
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407 bone marrow corresponds with the reported impairment of lipid storage capacity in intra-
408 abdominal WAT in these mice (Golding et al, 2017) and the impairment of lipid storage in 
409 cultured adipocytes from humans with PWS (Cadoudal et al, 2014).  Whether the obesity 
410 that usually accompanies PWS in humans leads to parallel changes in marrow adiposity 
411 remains to be established.
412
413 With this degree of leanness in the marrow, it is highly likely that the production of leptin 
414 from marrow adipocytes (Laharrague et al, 1998) is reduced in parallel.  Interestingly, 
415 intra-bone marrow infusion of leptin in GH-D rats not only halves marrow adiposity by 
416 suppressing adipogenesis, but increases osteoblast surface (Evans et al, 2011).  Given 
417 this role of leptin in maintaining the bone microenvironment, one would expect bones 
418 from PWS-ICdel mice to show evidence of elevated osteoblast activity.  However, while 
419 the function of PWS-ICdel osteoblasts should be examined in vitro, our data indicate that 
420 osteoblast activity does not appear to be enhanced in vivo.  Indeed, the combination of 
421 unaltered relative trabecular surface, a more fragmented trabecular lattice and an 
422 unchanged osteoclast density, imply that PWS-ICdel osteoblast number and/or activity is 
423 reduced.  The combined reduction in adipocytes and osteoblasts is unusual and 
424 suggests a failure in the proliferation of MSCs or their subsequent differentiation.
425
426 In the context of this endocrine and cellular milieu, the biomechanical integrity of the 
427 femoral cortex is clearly compromised.  Surprisingly, UTS, a measure of the strength of 
428 the calcified tissue, per se, is significantly increased.  Such increases in tissue strength 
429 usually result from a greater density of either matrix proteins or hydroxyapatite.  This is 
430 likely to be due to the reduction in GH-axis activity, producing slower growing and less 
431 remodelled bone (Locatelli & Bianchi, 2014).  Nevertheless, despite this increased tissue 
432 strength, the geometric component of strength (second moment of area) is profoundly 
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433 reduced, which corresponds directly with the smaller cortical diameter discussed above.  
434 Indeed, the impairment of this geometric component is more than sufficient to translate 
435 an elevated UTS into a compromised overall organ strength.
436
437 While the analysis of single-gene deletion models in this context is far from complete, the 
438 information available suggests some potential genetic mechanisms underlying the 
439 complex skeletal phenotype observed.  The impairment of the GH-axis may be due in 
440 part to the loss of expression of Snord116, because although Snord116del mice show 
441 normal pituitary volume, somatotroph number (Ding et al, 2008) and GH content (Burnett 
442 et al, 2017), circulating IGF-1 is reduced by 60-70% (Ding et al, 2008; Qi et al, 2016).  
443 This lack of GH action, possibly as the result of impaired activity of the hormone pro-
444 convertase enzyme PC1 (Burnett et al, 2017) increases GH-releasing hormone mRNA 
445 expression in the arcuate nucleus (Qi et al, 2016) reflecting impaired GH feedback.  In 
446 contrast, male Magel2del mice show normal IGF-1 levels, with IGF-1 secretion and 
447 ghrelin-induced (but not GHRH-induced) GH responses impaired in female mice 
448 (Tennese & Wevrick, 2011).  However, given the episodic nature of GH secretion in 
449 rodents, establishing the relationship between these specific genes and the parameters 
450 of spontaneous GH secretion would be more readily achieved in a larger species.
451
452 In the context of skeletal growth, body length is only modestly reduced in Snord116del 
453 mice, with a 10% reduction in bone mineral density (Ding et al, 2008; Qi et al, 2016).  
454 Although overall body length is normal in the absence of Magel2 (Bischof et al, 2007), 
455 femoral length, cortical diameter and cortical wall thickness are reduced in female 
456 Magel2del mice by 9-13% (Baraghithy et al, 2019).  Indeed, this is the only model in which 
457 a comprehensive analysis has been made of the skeletal phenotype.  Interestingly, 
458 although these mice also show comparable reductions in trabecular number, trabecular 
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459 fragmentation, femoral strength and UTS to that reported here in the PWS-ICdel mice, 
460 marrow adiposity is more than doubled (Baraghithy et al, 2019) compared to the 
461 profound reduction reported here.  This implies that loss of one of the other genes in the 
462 PWS locus either disrupts the relationship between adipocyte and osteoblast 
463 differentiation, or the proliferation of MSCs.  Since Necdin has already been identified as 
464 a regulator of astrocyte (Fujimoto et al, 2016), neocortical neural precursor cell 
465 (Minamide et al, 2014), hematopoietic stem cell (Asai et al, 2012) and pre-adipocyte 
466 (Fujiwara et al, 2012) differentiation, this seems like a potential candidate.
467
468 Given that the normal relationship between fat mass and bone remodelling is disrupted 
469 in PWS-ICdel mice, and our previous evidence that raising ambient temperature 
470 suppresses brown adipose tissue function (Golding et al, 2017), we investigated the 
471 effects of maintaining PWS-ICdel mice at thermoneutrality on this altered skeletal 
472 phenotype.  While this manipulation had no effect on marrow adiposity, there was a 
473 significant improvement in biomechanical strength as a result of an increased strength of 
474 the calcified tissue.  This is remarkable since we have previously shown that this 
475 manipulation halved food intake in PWS-ICdel mice (Golding et al, 2017).    When coupled 
476 with evidence that thermoneutrality normalises skeletal length and bone mineral density 
477 in Snord116del mice (Qi et al, 2017), this implies that bone turnover is dramatically 
478 reduced at thermoneutrality.  This interpretation is supported by evidence that 
479 thermoneutrality increases bone formation and reduces bone resorption in growing 
480 female C17BL/6J mice, while dramatically reducing food intake and doubling marrow 
481 adiposity (Iwaniec et al, 2016).  The latter observation serves to re-emphasize the likely 
482 impairment of adipocyte function in the PWS-ICdel model (Golding et al, 2017). 
483
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484 In summary, our data show that the longitudinal growth and biomechanical integrity of 
485 long bones are markedly impaired in the PWS-ICdel mouse model for “full” PWS.  
486 Whether this impairment is matched by deficits in the biomechanical properties of other 
487 types of bone, e.g. calvarial or vertebral bone, has yet to be established, but our data not 
488 only provide a biomechanical basis for the increased fracture risk in PWS (Butler et al, 
489 2002; Longhi et al, 2015), but indicate that thermoneutrality may be beneficial in this 
490 context.  The final phenotype observed in the PWS-ICdel mice appears to result from the 
491 combined loss of several genes from within the PWS locus, but a more precise genetic 
492 cause for the individual aspects remains to be fully elucidated.
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790 Figure Legends
791 Figure 1:  PWS-ICdel mice show impaired tibial growth and adiposity.  Quantification 
792 of tibial length (A), in 18-month old male WT (n=6) and PWS-ICdel (n=6) littermate mice.  
793 Tibial epiphysial plate (EP) width (B) was quantified in Masson’s Trichrome-stained 
794 sections and tibial marrow adiposity (C), marrow adipocyte number (D), size (E) and 
795 Size profile (F) quantified in digital images of Toluidene Blue-stained sections from WT 
796 (a) and PWS-ICdel (b) littermates.  Osteoclast density (G) was quantified in TRAP+-
797 stained sections.  Data shown are mean ± SEM (n=6 for both genotypes), with statistical 
798 comparisons performed by Student’s unpaired T-test (*P<0.05; **P<0.01; ***P<0.001 vs 
799 WT littermates).
800
801 Figure 2:  PWS-ICdel mice show impaired femoral morphology.  Measurement of 
802 femoral length (A), outer cortical (anterior-posterior) diameter (A-P Ø; B) and average 
803 cortical wall thickness (C) in 18-month old male WT (n=6 (3 for B & C)) and PWS-ICdel 
804 (n=6) littermate mice.  µ-CT was used to quantify the number (Tb.N; D), thickness 
805 (Tb.Th; E), cross-sectional shape (Structural modal (SM) index; F), relative surface 
806 (BS/BV; G), separation (Tb.Sp; H) and lattice fragmentation (Pattern factor; I) of 
807 trabeculae in the distal femora.  Data shown are mean ± SEM, with statistical 
808 comparisons performed by Student’s unpaired T-test (*P<0.05; **P<0.01 vs WT 
809 littermates).
810
811 Figure 3:  PWS-ICdel mice show compromised femoral strength.  Measurement of 
812 femoral strength (Ultimate moment; A), tissue strength (Ultimate tensile stress; B) and 
813 the geometric contribution to strength (Second moment of area; C) in 18-month old male 
814 WT (n=6 (3 for B & C)) and PWS-ICdel (n=6) littermate mice.  Data shown are mean ± 
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815 SEM, with statistical comparisons performed by Student’s unpaired T-test (*P<0.05 vs 
816 WT littermates).
817
818 Figure 4:  PWS-ICdel mice show multiple pituitary hormone deficiencies.  
819 Quantification of weight (A) and growth hormone (GH; B), prolactin (PRL; C) and 
820 luteinising hormone (LH; D) contents in 6-15-month old male and female WT (n=6) and 
821 PWS-ICdel (n=6 (male) and 5 (female)) littermate mice.  Data shown are mean ± SEM, 
822 with statistical comparisons performed by 1-way ANOVA and Bonferroni post hoc test 
823 (*P<0.05; **P<0.01; ***P<0.001; ****P<0.0001 vs WT littermates (same sex); ††P<0.01; 
824 †††† P<0.0001 vs male littermates (same genotype)).
825
826 Figure 5:  PWS-ICdel mice show reduced GH-IGF-1 axis activity.  Quantification of 
827 pituitary weight (A) and plasma insulin-like growth factor-1 (IGF-1; B), luteinising 
828 hormone (LH; C) and follicle stimulating hormone (FSH; D) in 5-9-month old male and 
829 female WT and PWS-ICdel (n=6 per group) littermate mice.  Data shown are mean ± 
830 SEM, with statistical comparisons performed by 1-way ANOVA and Bonferroni post hoc 
831 test (A & B) or Kruskal-Wallis test (C & D) (***P<0.001; ****P<0.0001 vs WT littermates 
832 (same sex); †††† P<0.0001 vs male littermates (same genotype)).
833
834 Figure 6:  Thermoneutrality has little effect on growth and marrow adiposity in 
835 PWS-ICdel mice.  Tibial length (A), epiphyseal plate (EP) width (B), marrow adiposity (C), 
836 marrow adipocyte number (D) and mean adipocyte size (E) were quantified in 6-15-
837 month old male WT and PWS-ICdel after being maintained at either standard ambient 
838 temperature (20-22°C) or thermoneutrality (30°C) for 9 weeks.  Adipocyte size profiles 
839 are presented for standard ambient temperature (F) and thermoneutrality (G).  Data 
840 shown are mean ± SEM (n=6 (room temperature) and 5 (thermoneutrality)), with 
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841 statistical comparisons performed by 1-way ANOVA and Bonferroni post hoc test (A-E; 
842 **** P<0.0001 vs room temperature (same genotype)) or unpaired Student’s t-test (F & 
843 G; * P<0.05 vs WT littermates (same temperature)).
844
845 Figure 7:  Thermoneutrality has little effect on growth and marrow adiposity in 
846 PWS-ICdel mice.  Tibial length (A), epiphyseal plate (EP) width (B), marrow adiposity (C), 
847 marrow adipocyte number (D) and mean adipocyte size (E) were quantified in 6-15-
848 month old male WT and PWS-ICdel after being maintained at either standard ambient 
849 temperature (20-22°C) or thermoneutrality (30°C) for 9 weeks (n=6 (room temperature) 
850 and 5 (thermoneutrality)).  Data shown are mean ± SEM, with statistical comparisons 
851 performed by 1-way ANOVA and Bonferroni post hoc test (**P<0.01; ****P<0.0001 vs 
852 WT littermates (same ambient temperature)).
853
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Braxton TM et al, 2019; Figure 1
Figure 1:  PWS-ICdel mice show impaired tibial growth and adiposity.  Quantification 
of tibial length (A), in 18-month old male WT (n=6) and PWS-ICdel (n=6) littermate mice.  
Tibial epiphysial plate (EP) width (B) was quantified in Masson’s Trichrome-stained 
sections and tibial marrow adiposity (C), adipocyte number (D), size (E) and Size profile 
(F) quantified in digital images of Toluidene Blue-stained sections from WT (a) and PWS-
ICdel (b) littermates.  Osteoclast density (G) was quantified in TRAP+-stained sections.  
Data shown are mean ± SEM (n=6 for both genotypes), with statistical comparisons 
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Braxton TM et al, 2019; Figure 2
Figure 2:  PWS-ICdel mice show impaired femoral morphology.  Measurement of 
femoral length (A), outer cortical (anterior-posterior) diameter (A-P Ø; B) and average 
cortical wall thickness (C) in 18-month old male WT (n=6 (3 for B & C)) and PWS-ICdel
(n=6) littermate mice.  µ-CT was used to quantify the number (Tb.N; D), thickness (Tb.Th; 
E), cross-sectional shape (Structural modal (SM) index; F), relative surface (BS/BV; G), 
separation (Tb.Sp; H) and lattice fragmentation (Pattern factor; I) of trabeculae in the 
distal femora.  Data shown are mean ± SEM, with statistical comparisons performed by 
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Braxton TM et al, 2019; Figure 3
Figure 3:  PWS-ICdel mice show compromised femoral strength.  Measurement of 
femoral strength (Ultimate moment; A), tissue strength (Ultimate tensile stress; B) and the 
geometric contribution to strength (Second moment of area; C) in 18-month old male WT 
(n=6 (3 for B & C)) and PWS-ICdel (n=6) littermate mice.  Data shown are mean ± SEM, 
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Braxton TM et al, 2019; Figure 4
Figure 4:  PWS-ICdel mice show multiple pituitary hormone deficiencies.  
Quantification of weight (A) and growth hormone (GH; B), prolactin (PRL; C) and 
luteinising hormone (LH; D) contents in 6-15-month old male and female  WT (n=6) and 
PWS-ICdel (n=6 (male) and 5 (female)) littermate mice.  Data shown are mean ± SEM, 
with statistical comparisons performed by 1-way ANOVA and Bonferroni post hoc test 
(*P<0.05; **P<0.01; ***P<0.001; ****P<0.0001 vs WT littermates (same sex); ††P<0.01; 
†††† P<0.0001 vs male littermates (same genotype)).
**
WT PWS-ICdel
Male Female Male Female
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Braxton TM et al, 2019; Figure 5
Figure 5:  PWS-ICdel mice show reduced GH-IGF-1 axis activity.  Quantification of 
pituitary weight (A) and plasma insulin-like growth factor-1 (IGF-1; B), luteinising hormone 
(LH; C) and follicle stimulating hormone (FSH; D) in 5-9-month old male and female WT 
and PWS-ICdel (n=6 per group) littermate mice.  Data shown are mean ± SEM, with 
statistical comparisons performed by 1-way ANOVA and Bonferroni post hoc test (A & B) 
or Kruskal-Wallis test (C & D) (***P<0.001; ****P<0.0001 vs WT littermates (same sex); 
†††† P<0.0001 vs male littermates (same genotype)).
WT PWS-ICdel
Male Female Male Female
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Braxton TM et al, 2019; Figure 6
Figure 6:  Thermoneutrality has little effect on growth and marrow adiposity in 
PWS-ICdel mice.  Tibial length (A), epiphyseal plate (EP) width (B), marrow adiposity (C), 
adipocyte number (D) and mean adipocyte size (E) were quantified in 6-15-month old 
male WT and PWS-ICdel after being maintained at either standard ambient temperature 
(20-22°C) or thermoneutrality (30°C) for 9 weeks.  Adipocyte size profiles are presented 
for standard ambient temperature (F) and thermoneutrality (G).  Data shown are mean ±
SEM (n=6 (room temperature) and 5 (thermoneutrality)), with statistical comparisons 
performed by 1-way ANOVA and Bonferroni post hoc test (A-E; **** P<0.0001 vs room 
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Braxton TM et al, 2019; Figure 7
Figure 7:  Thermoneutrality has little effect on growth and marrow adiposity in 
PWS-ICdel mice.  Tibial length (A), epiphyseal plate (EP) width (B), marrow adiposity (C), 
adipocyte number (D) and mean adipocyte size (E) were quantified in 6-15-month old 
male WT and PWS-ICdel after being maintained at either standard ambient temperature 
(20-22°C) or thermoneutrality (30°C) for 9 weeks (n=6 (room temperature) and 5 
(thermoneutrality)).  Data shown are mean ± SEM, with statistical comparisons performed 
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